Gubra released its Annual Report for 2024. Significant progress was made in 2024 across several R&D projects, not the least by advancement of the anti-obesity Amylin program where positive topline ...
The British media are jumping out of their pants, presenting the results of Prime Minister Keir Starmer's visit to US ...